Microbial contamination of clinical islet transplant preparations is associated with very low risk of infection
- PMID: 23438305
- PMCID: PMC3661032
- DOI: 10.1089/dia.2012.0297
Microbial contamination of clinical islet transplant preparations is associated with very low risk of infection
Abstract
Background: Several published studies have analyzed microbial contamination rates of islet products, ranging from 0% to 16%. However, few studies make reference to potential clinical consequences for transplant recipients and possible impact on islet survival.
Materials and methods: The current study defines rates of microbiological contamination of islet products under current good manufacturing practice conditions in 164 patients receiving 343 transplants at a single institution.
Results: Nineteen (5.5%) islet preparations showed positive microbial growth with a majority (79.4%) due to Gram-positive organisms. The most frequently identified microorganism was coagulase-negative Staphylococcus (nine of 19 [47.3%]), followed by polymicrobial organisms (eight of 19 [42.1%]). No patient developed signs of clinical infection, and there were no hepatic abscesses evident on imaging by ultrasound or magnetic resonance imaging (none of 19 [0%]), despite the use of potent T-depletional induction. Finally, we could not demonstrate any negative impact of microbiological contamination on long-term islet graft survival.
Conclusions: Microbiological contamination of the final islet preparation appears to have little or no effect on patients or on islet survival when appropriate antibiotics are given. However, preparation sterility should be guaranteed at all cost in order maximize patient safety and avoid potential complications in immunosuppressed patients.
Trial registration: ClinicalTrials.gov NCT00014911 NCT00175253 NCT00175266 NCT00434811 NCT00468403.
Figures
References
-
- Ryan EA. Bigam D. Shapiro AM. Current indications for pancreas or islet transplant. Diabetes Obes Metab. 2006;8:1–7. - PubMed
-
- Shapiro AM. Ricordi C. Hering BJ. Auchincloss H. Lindblad R. Robertson RP. Secchi A. Brendel MD. Berney T. Brennan DC. Cagliero E. Alejandro R. Ryan EA. DiMercurio B. Morel P. Polonsky KS. Reems J. Bretzel RG. Bertuzzi F. Froud T. Kandaswamy R. Sutherland DER. Eisenbarth G. Segal M. Preiksaitis J. Korbutt GS. Barton FS. Viviano L. Seyfert-Margolis V. Bluestone J. Lakey JRT. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355:1318–1330. - PubMed
-
- Taylor G. Kirkland T. Lakey J. Rajotte R. Warnock G. Bacteremia due to transplantation of contaminated cryopreserved pancreatic islets. Cell Transplant. 1994;3:103–106. - PubMed
-
- Bucher P. Oberholzer J. Bosco D. Mathe Z. Toso C. Bühler LH. Burney T. Morel P. Microbial surveillance during human pancreatic islet isolation. Transplant Int. 2005;18:584–589. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
